Financhill
Back

Novavax Quote, Financials, Valuation and Earnings

Novavax Price Quote

$8.72
+0.01 (+0.46%)
(Updated: December 21, 2024 at 5:39 AM ET)

Novavax Key Stats

Sell
25
Novavax (NVAX) is a Sell

Day range:
$8.37 - $8.89
52-week range:
$3.53 - $23.86
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.52
P/B ratio:
0%

Volume:
6.1M
Avg. volume:
4.9M
1-year change:
77.49%
Market cap:
$1.4B
Revenue:
$556.4M
EPS:
$-2.29

How Much Does Novavax Make?

Data Unavailable

Is Novavax Growing As A Company?

Data Unavailable

Novavax Stock Price Performance

  • Did Novavax Stock Go Up Last Month?
    Novavax share price went up by 8.13% last month
  • Did NVAX's Share Price Rise Over The Last Year?
    NVAX share price rose by 77.49% over the past 1 year

What Is Novavax 52-Week High & Low?

  • What Is Novavax’s 52-Week High Share Price?
    Novavax has traded as high as $23.86 over the past 52 weeks
  • What Is Novavax’s 52-Week Low Share Price?
    Novavax has traded as low as $3.53 over the past 52 weeks

Novavax Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Novavax?

Data Unavailable

Is Novavax Cash Flow Positive?

Data Unavailable

Novavax Return On Invested Capital

Data Unavailable

Novavax Earnings Date & Stock Price

  • What Is Novavax's Stock Price Today?
    A single share of NVAX can be purchased today for 8.72
  • What Is Novavax’s Stock Symbol?
    Novavax trades on the nasdaq under the ticker symbol: NVAX
  • When Is Novavax’s Next Earnings Date?
    The next quarterly earnings date for Novavax is scheduled on February 28, 2025
  • When Is NVAX's next ex-dividend date?
    Novavax's next ex-dividend date is December 22, 2024
  • How To Buy Novavax Stock?
    You can buy Novavax shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Novavax Competitors

  • Who Are Novavax's Competitors?
    Below is a list of companies who compete with Novavax or are related in some way:
    • Baxter International Inc (BAX)
    • Halozyme Therapeutics Inc (HALO)
    • Inovio Pharmaceuticals Inc (INO)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)

Novavax Dividend Yield

Data Unavailable

Novavax Analyst Estimates

YoY Growth Past Surprise
EPS: 70.69% -1.88%
Revenue: 283.03% 14.58%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 16.00
Upside from Last Price: 83.59%

Major Shareholders

Data Unavailable